ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Noven Pharmaceuticals Inc. 

11960 S.W. 144th Street

Miami  Florida  33186-5807  U.S.A.
Phone: 305-253-5099 Fax:


SEARCH JOBS








 Company News
Noven Pharmaceuticals Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/17/2014 9:55:46 AM    More...
Noven Pharmaceuticals Inc. Enters Co-Promotion Agreement With Shionogi, Inc. For Brisdelle™ (Paroxetine) Capsules 1/13/2014 12:08:31 PM    More...
Noven Pharmaceuticals Inc. Release: First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies 11/5/2013 7:45:50 AM    More...
Noven Pharmaceuticals Inc. Release: Data on Brisdelle™ (Paroxetine) Capsules, the First and Only FDA-Approved Non-Hormonal Therapy for Moderate to Severe Vasomotor Symptoms Associated with Menopause, to be Presented at the 2013 Annual Meeting of The North American Menopause Society 10/2/2013 9:55:23 AM    More...
FDA Panel Votes Against Approval of Noven Pharmaceuticals Inc.'s Menopause Drug 3/5/2013 8:00:41 AM    More...
FDA Accepts Noven Pharmaceuticals Inc.s NDA for an Investigational Nonhormonal Therapy for Menopausal Vasomotor Symptoms 11/13/2012 9:05:31 AM    More...
Noven Pharmaceuticals Inc.'s Nonhormonal Hot Flash Therapy Meets Phase III Goals 10/3/2012 6:40:55 AM    More...
Noven Pharmaceuticals Inc. (NOVN) Announces Commencement of Phase 2 Study of Investigational d-Amphetamine Transdermal System for ADHD 10/2/2012 10:18:14 AM    More...
Noven Pharmaceuticals Inc. (NOVN) Submits New Drug Application for Investigational Non-Hormonal Therapy for Menopausal Vasomotor Symptoms 8/29/2012 9:43:33 AM    More...
Noven Pharmaceuticals Inc. (NOVN) Provides Update on Lidoderm® Patent Challenge 7/2/2012 11:11:22 AM    More...
12345678910...